Baroness Shawcross-Wolfson Portrait

Baroness Shawcross-Wolfson

Conservative - Life peer

Became Member: 28th May 2025


Baroness Shawcross-Wolfson is not an officer of any APPGs Baroness Shawcross-Wolfson is not a member of any APPGs
Baroness Shawcross-Wolfson has no previous appointments


Division Voting information

During the current Parliament, Baroness Shawcross-Wolfson has voted in 94 divisions, and 2 times against the majority of their Party.

24 Feb 2026 - Tobacco and Vapes Bill - View Vote Context
Baroness Shawcross-Wolfson voted No - against a party majority and in line with the House
One of 13 Conservative No votes vs 72 Conservative Aye votes
Tally: Ayes - 78 Noes - 246
18 Mar 2026 - Crime and Policing Bill - View Vote Context
Baroness Shawcross-Wolfson voted No - against a party majority and in line with the House
One of 9 Conservative No votes vs 80 Conservative Aye votes
Tally: Ayes - 119 Noes - 191
View All Baroness Shawcross-Wolfson Division Votes

Debates during the 2024 Parliament

Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.

Sparring Partners
Baroness Smith of Malvern (Labour)
Minister of State (Department for Work and Pensions)
(3 debate interactions)
Baroness Lloyd of Effra (Labour)
Baroness in Waiting (HM Household) (Whip)
(2 debate interactions)
View All Sparring Partners
Department Debates
Ministry of Justice
(4 debate contributions)
Department for Work and Pensions
(3 debate contributions)
Home Office
(3 debate contributions)
HM Treasury
(1 debate contributions)
View All Department Debates
Legislation Debates
Crime and Policing Bill 2024-26
(2,860 words contributed)
Universal Credit Act 2025
(2,553 words contributed)
View All Legislation Debates
View all Baroness Shawcross-Wolfson's debates

Lords initiatives

These initiatives were driven by Baroness Shawcross-Wolfson, and are more likely to reflect personal policy preferences.


Baroness Shawcross-Wolfson has not introduced any legislation before Parliament

Baroness Shawcross-Wolfson has not co-sponsored any Bills in the current parliamentary sitting


Latest 50 Written Questions

(View all written questions)
Written Questions can be tabled by MPs and Lords to request specific information information on the work, policy and activities of a Government Department
1 Other Department Questions
23rd Jan 2026
To ask The Leader of the House when she expects a Written Answer to be given to the question asked by Baroness Shawcross-Wolfson on 10 December 2025 (HL12852).

The Department for Health and Social Care answered the question for written answer (HL12852) on 26th January 2026.

Baroness Smith of Basildon
Leader of the House of Lords and Lord Privy Seal
4th Mar 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 24 February (HL14386), how they will monitor whether individual departments and agencies change their hiring procedures and practices to place greater value on frontline delivery, innovation and private sector experience.

Departments and agencies have delegated authority to determine their own practices and procedures for the recruitment of staff to the Civil Service, including the Senior Civil Service (SCS), as outlined in the Civil Service Management Code.

The Government People Group are collaborating with dedicated SCS Recruitment leads from the core Government departments to support them in sharing best practice and making relevant changes to their hiring practices, in line with the ambition set out in the Chief Secretary to the Prime Ministers’ speech of 20 January 2026.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
6th Feb 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 28 January (HL14077), whether they will publish the changes they plan to make to the hiring criteria for senior civil servants, as set out in the speech by the Chief Secretary to the Prime Minister on 20 January.

Our approach to hiring for the Senior Civil Service (SCS) is changing to place greater value on frontline delivery, innovation, and private sector experience. Departments and agencies have authority to determine their practices and procedures for the recruitment of staff to the Civil Service, including the Senior Civil Service.

In accordance with the Civil Service Recruitment Principles, departments must provide all potential applicants with information about the nature and level of each role, criteria against which they will be assessed, and details of the selection process and the total remuneration available. However, there are no plans to publish internal-facing guidance to the public domain, as it constitutes HR-to-HR guidance designed for departments to integrate into their respective policies and processes.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
6th Feb 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 28 January (HL14077) and the speech by the Chief Secretary to the Prime Minister on 20 January, whether ministers will directly set key performance indicators (KPIs) for senior civil servants; and if so, how often performance will be measured against those KPIs; and how under-performance will be managed.

Performance arrangements for members of the Senior Civil Service stem from a centrally set performance management framework, which makes clear that the objectives should be linked directly to the objectives of the department and minister they serve.

Underperformance is managed under the same framework, and triggered when individuals fail to meet the minimum standards or receive low performance ratings, with sustained poor performance escalated to a separate formal policy aligned with ACAS best practice.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
28th Jan 2026
To ask His Majesty's Government, with regard to the speech by the Chief Secretary to the Prime Minister on 20 January, how key performance indicators (KPIs) for senior civil servants will be set by ministers; whether individual ministers will have total autonomy to set their own KPIs; over what time period those KPIs will be assessed; and whether those KPIs will be changed when a minister changes.

Performance arrangements for members of the Senior Civil Service stem from a centrally set performance management framework, which makes clear that the objectives should be linked directly to the objectives of the department and minister they serve. These are then assessed by their line manager, throughout the performance year.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
28th Jan 2026
To ask His Majesty's Government, with regard to the speech by the Chief Secretary to the Prime Minister on 20 January, which civil servants will have access to training from the National School of Government and Public Services; how many hours of training will be provided to civil servants; who will provide that training; and whether they will publish the proposed training curriculum.

His Majesty’s Government is establishing the National School of Government and Public Services to strengthen the professional capability of the Civil Service.

The National School will serve over half a million civil servants. It will provide hundreds of thousands of hours of training as well as on-demand online learning. Training will be provided by a combination of civil service trainers, senior civil servants, and external providers and experts, including leading academic institutions.

We currently publish details of civil service training and will continue to do so as we expand the curriculum, focusing on priority skills including digital and AI. Further details of the proposed training curriculum will be published when the National School launches later in 2026.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
22nd Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 19 January (HL13271), when they expect to publish the Civil Service strategic workforce plan; and whether they will detail its objectives.

The Civil Service is committed to publishing a Civil Service Strategic Workforce Plan in the first part of this year once departments have finalised their workforce plans as per the financial settlements that were agreed with HMT in the Spending Review and the priorities set by Ministers, including those set out in the Autumn Budget.

The Civil Service Strategic Workforce Plan will set out how the Civil Service workforce will meet the Government’s policies of reducing back office costs by 16% by 2030, halving consultancy spend and targeting spending on front line services.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
22nd Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 19 January (HL13271), whether they will detail their plans to reduce back-office costs in the Civil Service by 16 per cent over the next five years; and what savings will be achieved in each year up to 2030.

The Spending Review 2025 set each department’s yearly administration budget and committed to reduce them by 16% in total and in real terms by 2029-30. The Spending Review details the planned administration Budgets for each department for each year between 2025-26 and 2029-30.

The reductions will be delivered through savings and efficiencies, supported by the £150 million announced at Spring Statement 2025 to help deliver employee exit schemes, and with greater embedding of a cost-conscious culture across Whitehall, including reducing travel costs.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
20th Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 19 January (HL13276), when the arm's length bodies (ALB) review will be completed; and whether its findings will be published.

The review is ongoing. Outcomes will be communicated in due course.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
14th Jan 2026
To ask His Majesty's Government how many consultations they have launched since July 2024.

All government consultations are published on GOV.UK. Individual government departments are responsible for the consultations they lead on.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
14th Jan 2026
To ask His Majesty's Government what arm's-length bodies have been created since July 2024.

This Government was elected on a mandate of change. In order to deliver the promises we made in our manifesto, the following arms length bodies have been legislated for, launched or announced:

  • Great British Energy (DESNZ)

  • National Wealth Fund (HM Treasury)

  • Skills England (DWP)

  • Independent Football Regulator (DCMS)

  • Ethics and Integrity Commission (CO)

  • Single Construction Regulator (MHCLG)

  • Local Audit Office (MHCLG)

  • Government Commercial Agency (CO)

  • Great British Railways (DfT)

  • Fair Work Agency (DBT)

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
5th Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 2 January (HL13132), whether the arm's length bodies (ALB) review described as "recently completed" in paragraph 2.84 of the November 2025 Budget is a separate review to the one described as ongoing in this answer; and whether the decision to close NHS England, announced on 13 March 2025, was a result of either of these ALB reviews.

The reference in paragraph 2.84 of the November 2025 Budget refers to the arm's length body review that was launched on 6 April 2025. That review is ongoing. The decision to close NHS England, announced on 13 March 2025, predates the launch of the arm's length bodies (ALB) review.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
5th Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 2 January (HL13204), whether they expect the overall Civil Service headcount to decrease, stay the same, or increase between this year and 2030.

Departments are developing plans on the size and shape of their workforces as per the financial settlements that were agreed with HMT in the Spending Review and the priorities set by Ministers, including those set out in the Autumn Budget. These plans will take a whole workforce approach based on the cost of civil servants, Contingent Labour, Consultancy and Managed Services.

At an overall Civil Service level, we have set out plans to reduce back office costs by 16% over the next five years, delivering savings of over £2.2 billion a year by 2030 and targeting spending on front line services. The Civil Service is committed to publishing a Civil Service Strategic Workforce Plan this year, which will confirm more details about the plans for our workforce.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
18th Dec 2025
To ask His Majesty's Government (1) what the Civil Service headcount was in (a) 2023–24 and (b) 2024–2025; and; (2) what is the expected headcount for (a) 2025–26, (b) 2026–27, (c) 2027–28, (d) 2028–29, and (e) 2029–2030.

Please see the table below for 2024, 2025 and latest available figures on Civil Service employment sourced from ONS Public Sector Employment Statistics.

31 March 2024

31 March 2025

30 Sept 2025*

Full-time equivalent

510,720

516,470

520,440

Headcount

543,530

550,150

554,315

*latest available

Each department will take a decision on its future size and shape as per the financial settlements that were agreed with HM Treasury in the Spending Review. These plans will take a whole workforce approach based on the cost of civil servants, Contingent Labour, Consultancy and Managed Services, and will be finalised through the business planning process that is currently underway.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
18th Dec 2025
To ask His Majesty's Government when the review of arm’s length bodies will conclude; whether they have begun to implement its recommendations; and when the expect the implementation of recommendations to be completed.

The Arm's Length Body Review, formally launched on 7th April 2025 is ongoing, its outcomes will be communicated in due course. Some changes have already been announced such as the closure of NHS England to reduce bureaucracy, make savings and empower NHS staff to deliver better care for patients. Additionally, closures of some ALBs such as the UK Space Agency and its repatriation into DSIT are already underway..

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
17th Dec 2025
To ask His Majesty's Government what work they plan to undertake to make arm's-length bodies and the arm's-length body landscape more effective, efficient and accountable.

As announced on 6th April 2025, the Government is conducting a full-scale review of arm's-length bodies in order to reduce the duplication of work by public bodies, improve efficiency, reduce unnecessary costs, and improve transparency. This review is ongoing, but some changes have already been announced such as the closure of NHS England to reduce bureaucracy, make savings and empower NHS staff to deliver better care for patients.

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
22nd Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Lloyd of Effra on 22 January (HL13638), what assessment they have made of the cumulative impact of legislation passed since July 2024 on the administrative burden of regulation on business.

The Government has established a baseline for the administrative burden of regulation on businesses of £22.4bn a year, and a resulting £5.6bn target. As set out in the technical annex to policy paper ‘A new approach to ensure regulators and regulation support growth’ (21st October 2025), these estimates apply from the start of April 2025 and reflect all UK government regulation at the time, including since July 2024.

Where gross administrative burdens are added after April 2025, savings will be found in other areas, so the net administrative burden is reduced by £5.6bn by the end of this Parliament.

Baroness Lloyd of Effra
Baroness in Waiting (HM Household) (Whip)
22nd Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Lloyd of Effra on 22 January (HL13638), what assessment they have made of their progress in cutting the administrative burden of regulation on business.

Government is making progress to reduce the administrative burden of regulation on businesses by 25% by the end of this Parliament.

As set out in the October Regulation Action Plan progress update, we have identified £1.5bn in gross administrative savings through measures like the Planning and Infrastructure Bill which is accelerating the delivery of 1.5m new homes and critical infrastructure, making annual savings of £272m; modernising corporate reporting requirements, making annual savings of £230m, and; providing access to data and speeding up work to operate and repair pipes and cables by establishing the National Underground Asset Register, saving £185m annually.

Baroness Lloyd of Effra
Baroness in Waiting (HM Household) (Whip)
15th Jan 2026
To ask His Majesty's Government what specific targets they have to reduce government regulation.

The Government has published a comprehensive Regulation Action Plan that sets out our plans to reform the regulatory system to unlock growth, boost innovation and reduce burdens on businesses across key sectors.

One of the key commitments in the Action Plan is the target to cut the administrative burden of regulation on business by 25%, or £5.6bn, by the end of the Parliament. This pledge will save businesses time and money and help create a regulatory environment that is targeted, proportionate, transparent and agile enough to support economic growth.

Baroness Lloyd of Effra
Baroness in Waiting (HM Household) (Whip)
15th Jan 2026
To ask His Majesty's Government whether Young Futures Hubs will be co-located with, or work with, Family Hubs.

The Government is delivering a network of 50 Young Futures Hubs by March 2029. This is a cross-government priority, coordinated with the Department for Education and the Department of Health and Social Care.

While local authorities will decide on precise locations based on community needs, we expect co-location to be a key consideration where it improves accessibility and strengthens local support for young people.

Eight early adopters have been announced. The early adopter phase will look at how Young Futures Hubs interact with existing services, including Family Hubs.

Baroness Twycross
Baroness in Waiting (HM Household) (Whip)
26th Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Smith of Malvern on 5 January (HL13131), when they expect to be in a position to share more information on the planned review of childcare provision.

The Childcare Review is currently in the early stages of cross government discussions to consider how the early education and childcare alongside family support works for families and children. We will also be working with stakeholders throughout the year to gather insights and build our evidence base. We aim to conclude the Review later this year.

Baroness Smith of Malvern
Minister of State (Department for Work and Pensions)
17th Dec 2025
To ask His Majesty's Government what the timeframe is for the Department of Education’s review of childcare provision as announced in the Budget, and whether the terms of reference for this review will be published.

As announced in the Autumn Budget 2025, the department will lead a review of childcare provision. This review aims to simplify the system for providers and families, improving access and strengthening the impact of government support. The review is expected to take place in 2026, and we will share more information in due course.

Baroness Smith of Malvern
Minister of State (Department for Work and Pensions)
23rd Jan 2026
To ask His Majesty's Government what assessment they have made of the reasons why the number of child recipients of the Disability Living Allowance is increasing.

There have been steady increases over the last two decades in the number of children in receipt of Disability Living Allowance (DLAc), from 230,000 in May 2002 to 840,000 in May 2025, excluding Scotland claims. These increases are driven primarily by increases in the number of claimants with learning difficulties (including Autism Spectrum Disorder), hyperkinetic syndrome (including Attention Deficit Hyperactivity Disorder) and behavioural disorders which have increased from 48% of the caseload in May 2002 to 83% in May 2025.

Baroness Sherlock
Minister of State (Department for Work and Pensions)
5th Jan 2026
To ask His Majesty's Government what are their plans for reforming the Access to Work scheme, including the objectives and timetable of any such reform, and how they will involve disabled people and representative organisations.

This Government values the input of disabled people and people with health conditions, their representative organisations and people that support them. The Pathways to Work Green Paper launched a consultation which has now concluded. We are considering responses to the consultation.

We also have recently concluded the Access to Work Collaboration Committees, in which we engaged with a range of stakeholders, including disabled people’s organisation representatives and lived experience users, to provide discussion, experience, and challenge to the design of the future Access to Work Scheme.

Whilst the committees have now ended, we will seek opportunity to engage with stakeholders as we move forward with policy development, recognising the value of their input and expertise.

The findings from the consultation and Collaboration Committees will inform the chosen future direction of Access to Work. Once this is established we will set out our plans working closely with stakeholders to ensure an appropriate transition.

Baroness Sherlock
Minister of State (Department for Work and Pensions)
5th Jan 2026
To ask His Majesty's Government what pilots are currently underway to test reforms to the fit note system, including the locations and duration of those pilots, and the groups of patients and employers involved; what further reforms to the fit note system they are planning, beyond the current pilots; and when they expect to publish further details.

On 11th July 2025, we announced a WorkWell Primary Care Innovation Fund, which offered a portion of £1.5 million of single year funding to each of the fifteen WorkWell pilot sites to test innovative approaches to the fit note within primary care.

The funding is supporting local areas to boost capacity in primary care to provide better work and health support via the fit note process, with the longer term aims of reducing pressure on GPs and improving patients’ work and health outcomes.

Each of the 15 WorkWell Integrated Care Boards has received up to £100,000, with interventions running from October 2025 to March 2026. The locations of the sites are:

Birmingham and Solihull,

Black Country,

Bristol North Somerset and South Gloucestershire (BNSSG),

Cambridgeshire,

Cornwall and Isles of Scilly,

Coventry,

Frimley,

Greater Manchester,

Herefordshire,

Lancashire and South Cumbria,

Leicester, Leicestershire and Rutland (LLR),

North Central London,

North West London,

South Yorkshire, and

Surrey Heartlands.

One of the key aims of the funding is to build the evidence base for how the fit note process within primary care can be improved, and findings will inform future policy development. Most sites are using the funding to test new or additional roles within Primary Care Networks, including social prescribers, work and health coaches, or physiotherapists, to either issue the fit note instead of the GP or provide wraparound work and health support to the fit note recipient.

However, we know that we need to go further. The Keep Britain Working Review was clear that the fit note is ‘not working as intended’ and recommended that we test alternative approaches to the fit note, working with GPs and health services to explore improvements and replacements. We are currently considering how to respond to the Review’s recommendations on the fit note, and we will bring forward more information in due course.

Baroness Sherlock
Minister of State (Department for Work and Pensions)
5th Jan 2026
To ask His Majesty's Government what progress they have made on setting up the Workplace Health Intelligence Unit proposed in the Mayfield Review, and what its planned remit, governance arrangements, and timetable for operation are.

Work has commenced on the Keep Britain Working Vanguard Phase following publication of the review’s final report in November. We are working with Sir Charlie Mayfield, Vanguard employers and regions to mobilise and design this next phase of work and establish effective ways of working. The vanguards will play a pivotal role in shaping how health issues and disabilities are managed in the workplace, building an evidence base and understanding of what works through effective partnership with employers.

As part of the Vanguard Phase, Sir Charlie Mayfield has agreed to establish and lead a Vanguard Taskforce/advisory board in partnership with Department for Work and Pensions, Department for Business and Trade, and Department of Health and Social Care. The Vanguard Taskforce will bring together a group of external experts from various sectors and organisations to provide external advice, and guidance to steer the Keep Britain Working Vanguard Phase. We are currently considering the Terms of Reference and potential membership of the taskforce.

The Workplace Health Intelligence Unit (WHIU) will serve as the central hub for delivery of the whole Vanguard Phase and to drive on-going work. We are currently working to establish the Intelligence Unit within Government and considering options for its design and details of its function. A comprehensive governance framework, incorporating the taskforce, will be established to ensure strategic oversight and accountability of the Unit as it is set up and developed.

Further information on the shape and remit of the Vanguard Taskforce and Workplace Health Intelligence Unit is expected in Spring 2026.

Baroness Sherlock
Minister of State (Department for Work and Pensions)
5th Jan 2026
To ask His Majesty's Government what progress they have made on establishing the Vanguard taskforce proposed in the Mayfield Review, and when the taskforce is expected to start work.

Work has commenced on the Keep Britain Working Vanguard Phase following publication of the review’s final report in November. We are working with Sir Charlie Mayfield, Vanguard employers and regions to mobilise and design this next phase of work and establish effective ways of working. The vanguards will play a pivotal role in shaping how health issues and disabilities are managed in the workplace, building an evidence base and understanding of what works through effective partnership with employers.

As part of the Vanguard Phase, Sir Charlie Mayfield has agreed to establish and lead a Vanguard Taskforce/advisory board in partnership with Department for Work and Pensions, Department for Business and Trade, and Department of Health and Social Care. The Vanguard Taskforce will bring together a group of external experts from various sectors and organisations to provide external advice, and guidance to steer the Keep Britain Working Vanguard Phase. We are currently considering the Terms of Reference and potential membership of the taskforce.

The Workplace Health Intelligence Unit (WHIU) will serve as the central hub for delivery of the whole Vanguard Phase and to drive on-going work. We are currently working to establish the Intelligence Unit within Government and considering options for its design and details of its function. A comprehensive governance framework, incorporating the taskforce, will be established to ensure strategic oversight and accountability of the Unit as it is set up and developed.

Further information on the shape and remit of the Vanguard Taskforce and Workplace Health Intelligence Unit is expected in Spring 2026.

Baroness Sherlock
Minister of State (Department for Work and Pensions)
13th Nov 2025
To ask His Majesty's Government whether the report into young people and work will examine the reasons behind the number of young people claiming health and disability benefits.

We recognise that some young people are struggling to find their place in work, education or training.

The report into young people and work will seek to:

  • Understand the drivers of the increase in the number of young people who are Not in Education Employment or Training (NEET) and claiming health and disability benefits, including childhood experience
  • Investigate the root causes of this rise in economic inactivity among disabled young people and those with health conditions
  • Make recommendations for policy responses aimed at increasing opportunities for young people

The Right Honourable Alan Milburn will author the report and will be supported by a range of voices with expertise from the labour market and health spheres.

Baroness Sherlock
Minister of State (Department for Work and Pensions)
6th Mar 2026
To ask His Majesty's Government whether they intend that the 2026/27 NHS Payment Scheme consultation outcome in respect of guide prices for ADHD and autism assessments will be agreed to by Ministers before implementation.

The full responsibility for developing and setting the National Tariff, which is a set of rules, prices, and guidance that determine how providers of National Health Service funded healthcare are paid for the services they provide, was given to NHS England through the Health and Social Care Act 2012. The Health and Care Act 2022 confirmed this responsibility and renamed the ‘National Tariff’ to the ‘NHS Payment Scheme’. The legislation relating to the NHS Payment Scheme is set out in schedule 10 of the 2022 Act.

Under NHS England’s ‘Scheme of Delegation’, responsibility for approving the NHS Payment Scheme rests with the Chief Executive Officer of NHS England, delated to the Chief Financial Officer of NHS England. Ministerial agreement of the consultation is not currently a requirement of the regulations set out in the act.

NHS England will continue to work with policy teams at the Department and wider stakeholders to further develop currencies and consider appropriate payment options for attention deficit hyperactivity disorder and autism, in line with the overall direction set by ministers.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
5th Mar 2026
To ask His Majesty's Government what assessment they have made of NHS England's proposals in the consultation on the 2026/27 NHS Payment Scheme to set a £950 guide price for both adult and children and young people's autism assessments, given that children and young people's assessments includes additional components not required for adult assessments.

NHS England was advised by a number of clinicians, policy professionals, commissioners, and providers of attention deficit hyperactivity disorder (ADHD) and autism diagnostic assessment services prior to the publication of the NHS Payment Scheme consultation. All National Health Service providers, commissioners, and independent sector providers of NHS-funded autism and ADHD services were invited to an NHS Payment Scheme engagement session in September.

The statutory consultation for the NHS Payment Scheme 2026/27, which closed on 16 December 2025, provided an opportunity for all stakeholders to review the consultation guidance and provide comments and feedback. This consultation was open to the public, but NHS England specifically reached out to all NHS providers, commissioners, and independent sector providers of NHS-funded autism diagnostic assessment services and ADHD services to ensure they were aware and were able to respond to the NHS Payment Scheme consultation.

NHS England are currently reviewing this feedback to inform the final 2026/27 Payment Scheme.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
5th Mar 2026
To ask His Majesty's Government, in regard to the consultation on the 2026/27 NHS Payment Scheme, why NHS England have proposed the same guide price for adult and child autism assessments and different guide prices for child and adult attention deficit hyperactivity disorder assessments.

NHS England was advised by a number of clinicians, policy professionals, commissioners, and providers of attention deficit hyperactivity disorder (ADHD) and autism diagnostic assessment services prior to the publication of the NHS Payment Scheme consultation. All National Health Service providers, commissioners, and independent sector providers of NHS-funded autism and ADHD services were invited to an NHS Payment Scheme engagement session in September.

The statutory consultation for the NHS Payment Scheme 2026/27, which closed on 16 December 2025, provided an opportunity for all stakeholders to review the consultation guidance and provide comments and feedback. This consultation was open to the public, but NHS England specifically reached out to all NHS providers, commissioners, and independent sector providers of NHS-funded autism diagnostic assessment services and ADHD services to ensure they were aware and were able to respond to the NHS Payment Scheme consultation.

NHS England are currently reviewing this feedback to inform the final 2026/27 Payment Scheme.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
3rd Mar 2026
To ask His Majesty's Government what assessment they have made of the number of National Institute for Health and Care Excellence appraisals which are paused pending increases in the cost per quality-adjusted life year threshold in April.

There are currently two appraisals paused, at the request of the company, until the National Institute for Health and Care Excellence (NICE) has the power to apply the new cost-effectiveness threshold:

  • Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]; and
  • Ripretinib for treating advanced gastrointestinal stromal tumours after three or more treatments (review of TA881) [ID6496].

NICE anticipates that its cost-effectiveness threshold will increase in April 2026 and will provide a further update to stakeholders at that time.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
3rd Mar 2026
To ask His Majesty's Government whether they still plan to increase the National Institute for Health and Care Excellence cost per quality-adjusted life years thresholds in April; and what steps they will take to implement that increase.

The National Institute for Health and Care Excellence (NICE) currently assesses value for money for the National Health Service by applying a standard cost-effectiveness range of £20,000 to £30,000 per quality adjusted life year (QALY) gained over and above current treatments. As part of the landmark pharmaceuticals trade deal with the United States of America, it has been agreed that the cost-effectiveness threshold will be increased to £25,000 to £35,000 per QALY.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, does not currently have the legal power to direct NICE to amend the cost-effectiveness threshold used in its technology appraisal or highly specialised technology programmes. The Government has therefore proceeded to amend the NICE regulations, to give ministers a limited power of direction to set the core cost-effectiveness threshold that NICE uses in the development of guidance, and remove the requirement for NICE to consult on methods changes where these result from a ministerial direction. The regulation change has been made by a statutory instrument which was laid before Parliament on 3 March 2026 and, subject to the will of Parliament, will come into force on 24 March 2026. In line with the United Kingdom-United States’ deal, NICE will implement the cost-effectiveness threshold increase in April 2026, following a direction from my Rt Hon. Friend, the Secretary of State for Health and Social Care.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
24th Feb 2026
To ask His Majesty's Government what estimate they have made of the cash value of the productivity and efficiency savings to be made by NHS England, integrated care boards and NHS providers in order to fund the NHS Agenda for Change staff pay award 2026–27.

The Government has accepted the NHS Pay Review Body (NHSPRB) recommendation for a 2026/27 headline pay award, for all National Health Service staff on Agenda for Change (AfC), of a 3.3% pay rise effective from April 2026. We hugely appreciate the work of so many talented staff across the NHS. Accepting the recommendation gives NHS staff on AfC a deserved real terms pay rise.

The additional pressure above 2.5% affordability will be managed by the Department and the arms length bodies, including NHS England’s central budgets, but will not be paid for by cutting frontline services or an additional efficiency ask of integrated care boards and providers.

At the 2024 Autumn Statement and in our NHSPRB evidence, the Government reaffirmed its commitment to a 2% annual productivity growth target for the NHS and productivity is currently ahead of this target at 2.8% for the first seven months in this financial year. In 2025/26, systems have planned £11.1 billion of efficiencies and savings, or 7.1% of the total allocation. The planned efficiency and savings for the 2026/27 financial year will be finalised as part of the normal planning process that is currently underway.

Both efficiency and productivity performance is monitored on a monthly basis as part of our routine financial management to ensure the NHS lives within its budget.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
23rd Feb 2026
To ask His Majesty's Government what the cash value is of the productivity and efficiency savings they assumed in their submission to the NHS Pay Review Body for the NHS Agenda for Change staff pay award 2026–27; and whether they assumed those savings could be released (1) at the beginning of the financial year, or (2) during the financial year.

At the 2024 Autumn Statement, the Government reaffirmed its commitment to a 2% annual productivity growth target for the National Health Service. This is a stretching but essential ambition to ensure the NHS can meet rising demand within a tight financial settlement and return to pre-pandemic productivity levels. Detail on this was provided as part of the pay review body written evidence to give context to the wider NHS England financial position against which decisions are set.

Currently NHS productivity is running ahead of the 2% target, and increased by 2.8% in the first seven months of this financial year. This builds on the 2.7% growth between the 2024/25 and 2023/24 financial years. Consequently, we remain confident in delivering the 2% target.

The pay review body evidence did not set an explicit efficiency target. In practice, efficiency savings as a percentage run well ahead of 2% because they including non-recurrent savings and technical efficiencies, for instance reductions in agency costs, that are outside of productivity calculations. In 2024/25, NHS systems planned what was then the most ambitious efficiency and savings measures to date, targeting £9.3 billion, the equivalent to 6.1% of their total allocation. In 2025/26, systems have planned £11.1 billion of efficiencies and savings, 7.1% of the total allocation. NHS England will finalise planned efficiency and savings for the 2026/27 financial year as part of the normal planning process that is currently underway. Efficiencies are delivered throughout the course of the financial year, rather than all upfront at the start of the year.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
23rd Feb 2026
To ask His Majesty's Government what estimate they have made of (1) the total cost of the 2026–27 pay award for NHS Agenda for Change staff in England, and (2) the cost of that award above the affordability assumption set out in their evidence to the NHS Pay Review Body.

The Government has accepted the NHS Pay Review Body recommendation for the 2026/27 headline pay award, for all National Health Service staff on Agenda for Change terms and conditions in England, of a 3.3% consolidated pay rise effective from April 2026.

The pay uplift is above the Office for Budget Responsibility’s forecast inflation of 2.2% for 2026/27 and delivers a real terms pay rise for NHS staff.

The total cost for the 2026/27 pay award is estimated to be £3,250 million, and the likely impact above the 2.5% affordability assumption is estimated to be approximately £800 million. However, the exact cost will vary depending on the workforce size and composition during the year.

This additional pressure above affordability will be managed by the Department and our arms length bodies, including NHS England central budgets, but the pay increases will not be paid for by cutting frontline services.

It is vital that pay awards are fair for both workers and the taxpayer, so public services can deliver high-quality services across the country.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
11th Feb 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 2 February (HL13305), whether they expect a significant reduction in headcount in NHS England; and when they expect to reach their target for headcount reduction from the abolition of NHS England.

The Government’s ambition remains to reduce staff numbers by up to 50% across the Department of Health and Social Care, NHS England, and the integrated care boards. These reductions will be made by March 2028. NHS England’s voluntary redundancy scheme opened on 1 December and closed for applications on Tuesday 16 December. Colleagues have now been informed whether applications to the scheme were successful, however applications can be withdrawn at any time before final agreements are signed so we cannot yet confirm final numbers. The earliest date NHS England colleagues will start to leave under the scheme is 31 March. Our ambition is to let as many people leave voluntarily as possible and alongside ongoing recruitment controls and natural staff turnover, and we believe this will allow us to make significant progress towards the 50% headcount reduction.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
11th Feb 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 2 February (HL13305), what was the headcount at integrated care boards in (1) July 2024, and (2) the most recent period for which figures are available.

NHS England publishes monthly NHS Workforce Statistics which includes detailed statistics on staffing by individual trust and integrated care board (ICB). This publication has been used to supply a response to this question.

As of July 2024, there were 24,780 headcount staff working in ICBs across England. As of November 2025, this figure has decreased by 22 to 24,758 headcount staff working in ICBs across England. These numbers cover all staff employed directly by ICBs.

In April 2025 staff from two Commissiong Support Units, the NHS North of England Commissioning Support Unit and the NHS Midlands and Lancashire Commissioning Support Unit, transferred into the employment of their local ICBs, namely the NHS North East and Cumbria ICB and the NHS Staffordshire and Stoke-on-Trent ICB respectively. The impact of these moves was a one-off increase of 450 ICB staff across the two transfers.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
2nd Feb 2026
To ask His Majesty's Government, in regard to the UK–US pharmaceuticals deal, by what percentage of GDP the UK will increase spending on medicines; when that increase will be in place; and whether that increase applies to both private and public sources of spending.

The United Kingdom and United States’ pharmaceutical deal included a commitment to raise spending on innovative medicines, as a proportion of gross domestic product, from approximately 0.3% to 0.35% by the end of 2028 and to 0.6% over a 10-year period. This represents approximate rises of 0.05% by 2028 and 0.3% over a 10-year period respectively, versus the starting position estimated. Further detail, including data sources, will be confirmed in due course.

As part of the US and UK trade agreement, NHS England and the National Institute for Health and Care Excellence (NICE) produced joint analysis to estimate the cost impact of implementing two potential measures into the pricing environment, specifically an increase of NICE’s standard threshold range to £25,000 to £35,000 per Quality Adjusted Life Year (QALYs), and the introduction of the EQ5D-5L value set for estimating QALYs.

NICE’s analysis estimated the expected price impacts for new medicine launches based on a retrospective analysis of previous recommendations, including assumptions around the potential for an increase in the number of positive recommendations. NHS England applied these assumptions to a generalised projection of spend on new medicines and new indications over the next three years. The analysis assumes that the profile of spend associated with medicines expected to launch in future will follow the same average growth profile as has been observed historically.

The analysis suggests that the majority of the price increase will result from the change to the cost effectiveness thresholds, but the exact contribution of each will depend on which medicines NICE recommends for National Health Service use. This is not something that we can predict at this time as it depends on which drugs come to market and which are assessed as approved for use on the NHS accordingly.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
2nd Feb 2026
To ask His Majesty's Government, in regard to the press release about the UK–US pharmaceuticals deal issued on 1 December 2025, what was the specific basis on which the 25 per cent increase in medicine pricing was calculated; and what proportion of that increase corresponds to (1) a change to the cost effectiveness thresholds, and (2) the introduction of a new value set for judging health states.

The United Kingdom and United States’ pharmaceutical deal included a commitment to raise spending on innovative medicines, as a proportion of gross domestic product, from approximately 0.3% to 0.35% by the end of 2028 and to 0.6% over a 10-year period. This represents approximate rises of 0.05% by 2028 and 0.3% over a 10-year period respectively, versus the starting position estimated. Further detail, including data sources, will be confirmed in due course.

As part of the US and UK trade agreement, NHS England and the National Institute for Health and Care Excellence (NICE) produced joint analysis to estimate the cost impact of implementing two potential measures into the pricing environment, specifically an increase of NICE’s standard threshold range to £25,000 to £35,000 per Quality Adjusted Life Year (QALYs), and the introduction of the EQ5D-5L value set for estimating QALYs.

NICE’s analysis estimated the expected price impacts for new medicine launches based on a retrospective analysis of previous recommendations, including assumptions around the potential for an increase in the number of positive recommendations. NHS England applied these assumptions to a generalised projection of spend on new medicines and new indications over the next three years. The analysis assumes that the profile of spend associated with medicines expected to launch in future will follow the same average growth profile as has been observed historically.

The analysis suggests that the majority of the price increase will result from the change to the cost effectiveness thresholds, but the exact contribution of each will depend on which medicines NICE recommends for National Health Service use. This is not something that we can predict at this time as it depends on which drugs come to market and which are assessed as approved for use on the NHS accordingly.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
27th Jan 2026
To ask His Majesty's Government, further to the Written  Answer by Baroness Merron on 26 January (HL12852), whether they intend to apply the increased cost-effectiveness threshold to technology evaluated through the National Institute for Health and Care Excellence’s HealthTech guidance evaluation programme, or only to technology evaluated through the National Institute for Health and Care Excellence technology appraisals programme.

No decision has yet been taken on whether the increased cost-effectiveness threshold will apply to medical technologies that are evaluated by the National Institute for Health and Care Excellence through its HealthTech programme.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
22nd Jan 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 13 January (HL13304), what plans there are for co-operation between the Independent Review for Mental Health Conditions, ADHD and Autism and the Young People and Work Report led by Alan Milburn.

The Independent Review for Mental Health Conditions, ADHD, and Autism, and the Young People and Work Report led by Alan Milburn are complementary. The chairs and the secretariats are in regular discussion to ensure cooperation.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
6th Jan 2026
To ask His Majesty's Government whether they have appointed an advisory working group for the Independent Review for Mental Health Conditions, ADHD and Autism, announced on 4 December 2025; and whether they will make the membership of that group public.

The review will appoint an Advisory Working Group which involves a multidisciplinary group of leading academics, clinicians, epidemiological experts, charities, and people with lived experience to directly shape the recommendations and scrutinise the evidence.

As the review is independent of the Government, it is for the chairs to determine what information regarding the review is made public.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
6th Jan 2026
To ask His Majesty's Government, for the Department of Health and Social Care and each of its arm's length bodies, how many full-time equivalent staff they employ; and what their headcount was in (1) July 2024, and (2) the most recent period for which figures are available.

The Department publishes this information online, on the GOV.UK website.

The table below shows the headcount and full-time equivalent (FTE) headcount of staff employed by the Department and each of its arm’s length bodies, as of July 2024 and November 2025, the most recent figures available.

Agency

July 2024

November 2025

Headcount

FTE

Headcount

FTE

Department of Health and Social Care (excl. agencies)

3,450

3,340

3,583

3,463

Care Quality Commission

3,598

3,413

3,661

3,480

Health Research Authority

263

249

276

263

Human Fertilisation & Embryology Authority

74

67

84

76

Human Tissue Authority

54

54

59

59

Medicines & Healthcare products Regulatory Authority

1,402

1,359

1,604

1,560

National Institute for Health and Care Excellence

822

750

843

775

NHS Blood and Transplant

6,429

5,730

6,726

5,996

NHS Business Services Authority

4,707

4,410

5,524

5,204

NHS England

15,674

14,210

15,633

14,160

NHS Resolution

764

734

870

837

UK Health Security Agency

5,951

5,643

5,802

5,537

NHS Counter Fraud Authority

--

--

230

225

Health Services Safety Investigations Body

--

--

51

44

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
10th Dec 2025
To ask His Majesty's Government whether the new National Institute for Health and Care Excellence cost-effectiveness thresholds for assessing medicines will apply to other medical technologies.

The Government’s intention is that the increased cost-effectiveness threshold will apply to any technology, including medicines and medical technologies, evaluated through the National Institute for Health and Care Excellence (NICE) technology appraisals programme.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
5th Dec 2025
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 27 November (HL11874), whether the forthcoming 10 Year Workforce Plan will set out specific forecasts for the number of staff the NHS needs over those 10 years; whether they will publish the assumptions used to produce that plan; and whether the National Audit Office will make an assessment of that plan.

The 10 Year Workforce Plan will ensure the National Health Service has the right people in the right places, with the right skills to care for patients, when they need it. It will include modelling of the potential size and shape of the future workforce and implications for major professions.

The updated workforce modelling, and its underlying assumptions, will be set out in and alongside the plan when published in spring 2026. It will be supported by external independent scrutiny. A decision on whether the National Audit Office will be asked to make an assessment of the plan has not yet been made.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
12th Nov 2025
To ask His Majesty's Government what is the present, and planned intake for (1) medical school places, (2) GP trainees, (3) nursing trainees, (4) nursing associate trainees, (5) midwifery trainees, (6) pharmacist trainees, and (7) dentist trainees in (a) 2025, (b) 2026, (c) 2028, and (d) 2031.

In England, the Office for Students (OfS) sets the maximum fundable limit for medical school and dental school places on an annual basis. For the 2025/26 academic year, the OfS has published its intake target at 8,126 for medical school places and 809 for dental school places. The latest published medical and dental intake data is available on the OfS website. The number of dental and medical school places taken is as follows:

  • 8,045 medicine places; and
  • 810 dentistry places.

The data above is initial data from 2024 and so may change. General practice training places are set out annually by NHS England.

Undergraduate training places for nurses, nurse associates, midwives, and pharmacists are not centrally commissioned by the Government. Instead, they are determined by local employers and education providers who decide the number of learners they admit based on learner demand and provider capacity funding. The number of acceptances for nursing and midwifery is:

  • 18,640 for nursing; and
  • 3,390 for midwifery.

The above data is from 2025, was taken 28 days after A-level results day, and is not final data. Further information is available on the UCAS website. The number of entrants to pharmacy courses was 3,880, as per data from 2023. Further information is available on the Higher Education Statistics Agency website, in an online only format. Data is not available for nurse associates

The Government is committed to publishing a 10 Year Workforce Plan which will ensure the National Health Service has the right people in the right places, with the right skills to care for patients, when they need it.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)